VINC - Vincerx Pharma, Inc.
0.1
-0.033 -33.300%
Share volume: 4,482,550
Last Updated: 04-22-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.13
-0.03
-0.25%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-12-2024 | 03-27-2025 | 05-15-2025 | |
| Assets | ||||||
| Total Assets | 11.083 M | 21.527 M | 14.947 M | 8.005 M | 4.686 M | |
| Current Assets | 7.677 M | 18.283 M | 11.748 M | 6.410 M | 4.686 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.785 M | 1.352 M | 1.294 M | 1.255 M | 44.000 K | |
| Short Term Investments | 0.000 | 8.396 M | 7.144 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.110 M | 7.923 M | 2.942 M | 4.987 M | 4.437 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 111.000 K | 98.000 K | 85.000 K | 0.000 | 0.000 | |
| Other Assets | 3.295 M | 3.146 M | 3.114 M | 1.595 M | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 11.083 M | 21.527 M | 14.947 M | 8.005 M | 4.686 M | |
| Total liabilities | 11.705 M | 6.079 M | 5.839 M | 5.281 M | 2.620 M | |
| Total current liabilities | 10.634 M | 5.332 M | 5.424 M | 5.281 M | 2.620 M | |
| Accounts Payable | 2.314 M | 1.536 M | 1.963 M | 2.029 M | 2.269 M | |
| Other liabilities | 1.071 M | 747.000 K | 415.000 K | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.071 M | 747.000 K | 415.000 K | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -622.000 K | 15.448 M | 9.108 M | 2.724 M | 2.066 M | |
| Common stock | 170.859 M | 188.773 M | 190.196 M | 191.791 M | 196.082 M | |
| Retained earnings | -171.541 M | -173.349 M | -181.192 M | -189.186 M | -194.186 M |